|Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes|
S Xia, J Feng, L Lei, J Hu, L Xia, J Wang, Y Xiang, L Liu, S Zhong, L Han, ...
Briefings in bioinformatics 18 (6), 984-992, 2017
|A pan-cancer analysis of the expression and clinical relevance of small nucleolar RNAs in human cancer|
J Gong, Y Li, C Liu, Y Xiang, C Li, Y Ye, Z Zhang, DH Hawke, PK Park, ...
Cell reports 21 (7), 1968-1981, 2017
|PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types|
J Gong, S Mei, C Liu, Y Xiang, Y Ye, Z Zhang, J Feng, R Liu, L Diao, ...
Nucleic acids research 46 (D1), D971-D976, 2018
|A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles|
W Tao, C Xu, Q Ding, R Li, Y Xiang, J Chung, J Zhong
Virology 395 (1), 67-76, 2009
|Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer|
N Zhao, J Cao, L Xu, Q Tang, LE Dobrolecki, X Lv, M Talukdar, Y Lu, ...
The Journal of clinical investigation 128 (4), 1283-1299, 2018
|HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells|
W Chen, Y Xu, H Li, W Tao, Y Xiang, B Huang, J Niu, J Zhong, G Meng
PloS one 9 (1), e84953, 2014
|Identification of cholesterol 25-hydroxylase as a novel host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection|
Y Xiang, JJ Tang, W Tao, X Cao, BL Song, J Zhong
Journal of virology 89 (13), 6805-6816, 2015
|LNCediting: a database for functional effects of RNA editing in lncRNAs|
J Gong, C Liu, W Liu, Y Xiang, L Diao, AY Guo, L Han
Nucleic acids research 45 (D1), D79-D84, 2017
|The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy|
Y Ye, Y Xiang, FM Ozguc, Y Kim, CJ Liu, PK Park, Q Hu, L Diao, Y Lou, ...
Cell systems 6 (3), 314-328. e2, 2018
|Comprehensive characterization of alternative polyadenylation in human cancer|
Y Xiang, Y Ye, Y Lou, Y Yang, C Cai, Z Zhang, T Mills, NY Chen, Y Kim, ...
JNCI: Journal of the National Cancer Institute 110 (4), 379-389, 2018
|Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy|
Y Ye, Q Hu, H Chen, K Liang, Y Yuan, Y Xiang, H Ruan, Z Zhang, A Song, ...
Nature metabolism 1 (4), 431-444, 2019
|Inhibition of hepatitis C virus infection by polyoxometalates|
Y Qi, Y Xiang, J Wang, Y Qi, J Li, J Niu, J Zhong
Antiviral research 100 (2), 392-398, 2013
|Current research on non-coding ribonucleic acid (RNA)|
J Wang, DC Samuels, S Zhao, Y Xiang, YY Zhao, Y Guo
Genes 8 (12), 366, 2017
|Comprehensive characterization of circular RNAs in~ 1000 human cancer cell lines|
H Ruan, Y Xiang, J Ko, S Li, Y Jing, X Zhu, Y Ye, Z Zhang, T Mills, J Feng, ...
Genome medicine 11 (1), 1-14, 2019
|A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate|
J Lu, Y Xiang, W Tao, Q Li, N Wang, Y Gao, X Xiang, Q Xie, J Zhong
Journal of virology 88 (3), 1484-1491, 2014
|Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer|
Z Zhang, JH Lee, H Ruan, Y Ye, J Krakowiak, Q Hu, Y Xiang, J Gong, ...
Nature communications 10 (1), 1-12, 2019
|Casein kinase II controls TBK1/IRF3 activation in IFN response against viral infection|
M Du, J Liu, X Chen, Y Xie, C Yuan, Y Xiang, B Sun, K Lan, M Chen, ...
The Journal of Immunology 194 (9), 4477-4488, 2015
|Expression of long noncoding RNA YIYA promotes glycolysis in breast cancer|
Z Xing, Y Zhang, K Liang, L Yan, Y Xiang, C Li, Q Hu, F Jin, V Putluri, ...
Cancer research 78 (16), 4524-4532, 2018
|Neutrophils promote tumor resistance to radiation therapy|
AJ Wisdom, CS Hong, AJ Lin, Y Xiang, DE Cooper, J Zhang, ES Xu, ...
Proceedings of the National Academy of Sciences 116 (37), 18584-18589, 2019
|CircView: a visualization and exploration tool for circular RNAs|
J Feng, Y Xiang, S Xia, H Liu, J Wang, FM Ozguc, L Lei, R Kong, L Diao, ...
Briefings in Bioinformatics 20 (3), 745-751, 2019